Paul Choi

Stock Analyst at Goldman Sachs

(0.82)
# 2433
Out of 5,441 analysts
143
Total ratings
Success rate
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
AMRN Amarin Corp
Maintains: Sell
7 12
14.88 -19.35% 8 Jun 25, 2025
URGN UroGen Pharma
Maintains: Neutral
16 3
18.27 -83.58% 4 May 22, 2025
GOSS Gossamer Bio
Maintains: Strong Buy
7 8
1.74 359.77% 6 May 16, 2025
PHAT Phathom Pharmaceutic...
Maintains: Neutral
10 5
10.3 -51.46% 10 May 2, 2025
ARVN Arvinas
Maintains: Neutral
12 8
6.58 21.58% 3 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 52
34.12 52.4% 2 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 21
4.28 390.65% 8 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
14 12
7.46 60.86% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 3
1.85 62.16% 9 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 10
10.47 -4.49% 4 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 225
195.94 14.83% 4 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
143
56.07 155.04% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
32 42
43.3 -3% 7 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
85 60
33.2 80.72% 2 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 19
15.44 23.06% 6 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 32
32.74 -2.26% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 50
48.24 3.65% 6 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 19
4.69 305.12% 3 Jun 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
400 50
8.4 495.24% 7 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 26
2.65 881.13% 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 4
1.54 159.74% 1 Oct 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 25
1.4 1685.71% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
450 100
n/a n/a 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 4
n/a n/a 4 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 4
5.87 -40.37% 1 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
151 170
13.43 1165.82% 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 125
n/a n/a 2 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
9 8
4.85 64.95% 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
132
178.75 -26.15% 3 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
33
30 10% 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
112
46.99 138.35% 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30
26.98 11.19% 1 Jan 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
48 49
n/a n/a 4 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
91 103
n/a n/a 2 Jul 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
135
123.99 8.88% 1 Jun 29, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
240
0.7 34185.71% 2 Jun 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
5 22
n/a n/a 3 Apr 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
270 300
22.48 1234.52% 2 Mar 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 40
n/a n/a 3 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
60 56
74.96 -25.29% 3 Aug 6, 2018